Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOCH-R vs R-VACOP-B in Primary Mediastinal Large B-Cell Lymphoma
NCT00983944Phase 2Withdrawn
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Sep 2009
- Primary completion
- Apr 2011
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in primary mediastinal large B-cell lymphoma (PMBCL), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Planned start Sep 2009; status: withdrawn.
02
Drugs
rituximab
03
Conditions
primary mediastinal large B-cell lymphoma (PMBCL)
Beyond the preview
Go deeper on NCT00983944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983944.